A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. [PDF]
The unprecedented scale of the Ebola outbreak in West Africa has, as of 29 April 2015, resulted in more than 10,884 deaths among 26,277 cases. Prior to the ongoing outbreak, Ebola virus disease (EVD) caused relatively small outbreaks (maximum outbreak ...
Bento, AI+4 more
core +1 more source
Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions. [PDF]
The filoviruses, Marburg and Ebola, have the dubious distinction of being associated with some of the highest case-fatality rates of any known infectious disease-approaching 90% in many outbreaks.
A.G. Sprecher+105 more
core +2 more sources
BACKGROUND The filovirus Bundibugyo virus (BDBV) causes severe disease with a mortality rate of ∼20-51%. The only licensed filovirus vaccine in the U.S., Ervebo®, consists of a recombinant vesicular stomatitis virus (rVSV) vector that expresses Ebola ...
Courtney Woolsey+11 more
semanticscholar +1 more source
Ebola Haemorrhagic Fever in Africa: a Necessary Highlight [PDF]
The purpose of this commentary is to re-evaluate the historic and scientific facts on Ebola haemorrhagic fever and the role of the International community, especially Economic Community of West African States (ECOWAS) in stemming the tide.
Adu-Gyamfi, S. (Samuel)
core +3 more sources
Presence and persistence of Ebola or Marburg virus in patients and survivors: A rapid systematic review [PDF]
Background: The 2013-15 Ebola outbreak was unprecedented due to sustainedtransmission within urban environments and thousands of survivors. In 2014 the World Health Organization stated that there was insufficient evidence to give definitive guidance ...
Brainard, Julii+4 more
core +3 more sources
Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008 [PDF]
A confirmed Ebola haemorrhagic fever (EHF) outbreak in Bundibugyo, Uganda, November 2007-February 2008, was caused by a putative new species (Bundibugyo ebolavirus). It included 93 putative cases, 56 laboratory-confirmed cases, and 37 deaths (CFR = 25%).
A Grolla+66 more
core +3 more sources
Background This review aimed to systematically evaluate the immunogenicity and safety of the candidate Ebola virus vaccine (EVV). Methods We searched five databases for randomized controlled trials (RCTs) evaluating the effects of EVV on healthy adults ...
Juntao Yin+4 more
semanticscholar +1 more source
Virological diagnosis of Ebolavirus infection
Ebolaviruses, and the other viral causes of haemorrhagic fevers (VHF) have always posed special problems for diagnostic laboratories. These arise from the rarity of human infections, minimal documented experience with test delivery and interpretation, the paucity of established commercial or in-house assays, the lack of clinical material for test ...
Dominic E. Dwyer+6 more
openaire +3 more sources
Re-emerging infectious diseases: Ebola hemorrhagic fever [PDF]
The spring of 2014 has brought a new calamity, the exotic infectious disease: Ebola Hemorrhagic Fever, which is caused by a highly contagious and pathogenic virus, transmitted directly by interpersonal contact or indirectly by common usage of objects ...
Lucia E. Ionescu+2 more
doaj
Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats [PDF]
Biological factors that influence the host range and spillover of Ebola virus (EBOV) and other filoviruses remain enigmatic. While filoviruses infect diverse mammalian cell lines, we report that cells from African straw-colored fruit bats (Eidolon helvum)
Agnarsson+78 more
core +2 more sources